✦ LIBER ✦

Platelet Function Measurement in Elective Percutaneous Coronary Intervention Patients: Exploring the Concept of a P2Y12 Inhibitor Therapeutic Window

✍ Scribed by Udaya S. Tantry; Young-Hoon Jeong; Eliano P. Navarese; Paul A. Gurbel

Book ID: 119289472
Publisher: American College of Cardiology
Year: 2012
Tongue: English
Weight: 156 KB
Volume: 5
Category: Article
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2012.01.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic assessment of a novel P2

Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention

✍ Hiroyoshi Yokoi; Takeshi Kimura; Takaaki Isshiki; Hisao Ogawa; Yasuo Ikeda 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 369 KB

A head-to-head comparison between the Ve

A head-to-head comparison between the VerifyNow® P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention

✍ J. W. VAN WERKUM; C. A. K. VAN DER STELT; T. H. SEESING; C. M. HACKENG; J. M. TE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

A Comparison of INNOVANCE® PFA P2Y and V

A Comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 Assay for the Assessment of Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention

✍ Jiyoung Jang; Jihyang Lim; Kiyuk Chang; Yonggoo Kim; Myungshin Kim; Hae il Park; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

A Therapeutic Window for Platelet Reacti

A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty–Platelet Reactivity for Outcome Validation Effort) Study

✍ Fabio Mangiacapra; Giuseppe Patti; Emanuele Barbato; Aaron J. Peace; Elisabetta 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 954 KB

Rationale and design of the randomized,

Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)

✍ Sergio Leonardi; Sunil V. Rao; Robert A. Harrington; Deepak L. Bhatt; C. Michael 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 375 KB

The Efficacy and Safety of Prasugrel Wit

The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38) Analysis

✍ Michelle O'Donoghue; Elliott M. Antman; Eugene Braunwald; Sabina A. Murphy; P. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 480 KB